CN112690351A - Millettia speciosa-intelligence-benefiting tea beverage as well as preparation method and application thereof - Google Patents
Millettia speciosa-intelligence-benefiting tea beverage as well as preparation method and application thereof Download PDFInfo
- Publication number
- CN112690351A CN112690351A CN202011570031.2A CN202011570031A CN112690351A CN 112690351 A CN112690351 A CN 112690351A CN 202011570031 A CN202011570031 A CN 202011570031A CN 112690351 A CN112690351 A CN 112690351A
- Authority
- CN
- China
- Prior art keywords
- parts
- tea
- composition
- tea beverage
- flower
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000013616 tea Nutrition 0.000 title claims abstract description 55
- 241000521581 Millettia Species 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims description 13
- 239000000203 mixture Substances 0.000 claims abstract description 44
- 210000004369 blood Anatomy 0.000 claims abstract description 32
- 239000008280 blood Substances 0.000 claims abstract description 32
- 241000572565 Alpinia oxyphylla Species 0.000 claims abstract description 24
- 235000019224 Camellia sinensis var Qingmao Nutrition 0.000 claims abstract description 19
- 235000020339 pu-erh tea Nutrition 0.000 claims abstract description 19
- 241000723353 Chrysanthemum Species 0.000 claims abstract description 18
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 18
- 244000062241 Kaempferia galanga Species 0.000 claims abstract description 14
- 235000013421 Kaempferia galanga Nutrition 0.000 claims abstract description 14
- 235000000346 sugar Nutrition 0.000 claims abstract description 13
- 240000002768 Alpinia galanga Species 0.000 claims abstract description 9
- 235000006887 Alpinia galanga Nutrition 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
- 241000628997 Flos Species 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 9
- 239000012467 final product Substances 0.000 claims description 9
- 230000001954 sterilising effect Effects 0.000 claims description 9
- 241001098027 Callerya speciosa Species 0.000 claims description 7
- 239000000047 product Substances 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 6
- 230000000694 effects Effects 0.000 abstract description 8
- 238000000855 fermentation Methods 0.000 abstract description 4
- 230000004151 fermentation Effects 0.000 abstract description 4
- 239000013589 supplement Substances 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 244000269722 Thea sinensis Species 0.000 abstract 3
- 230000000052 comparative effect Effects 0.000 description 24
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 20
- 210000002966 serum Anatomy 0.000 description 14
- 239000003814 drug Substances 0.000 description 13
- 238000003304 gavage Methods 0.000 description 10
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 10
- 241000700159 Rattus Species 0.000 description 9
- 241001122767 Theaceae Species 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 208000031226 Hyperlipidaemia Diseases 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 208000008589 Obesity Diseases 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- 238000010025 steaming Methods 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 238000003975 animal breeding Methods 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 239000003833 bile salt Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 238000009207 exercise therapy Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000000055 hyoplipidemic effect Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000010699 lard oil Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000001050 pharmacotherapy Methods 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/163—Liquid or semi-liquid tea extract preparations, e.g. gels, liquid extracts in solid capsules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/166—Addition of, or treatment with, enzymes or microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Medical Informatics (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Medicines Containing Plant Substances (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
The invention provides a composition for preparing a tea beverage for reducing blood sugar and blood fat, which comprises the following components: 40-50 parts of beautiful millettia root, 20-30 parts of alpinia oxyphylla flower, 10-20 parts of galangal flower, 10-20 parts of chrysanthemum and 40-50 parts of Pu' er tea. The invention also provides the beautiful millettia root-intelligence-improving tea drink prepared by fermenting the composition. The radix millettiae speciosae tea is prepared by combining radix millettiae speciosae, the alpinia galanga, the chrysanthemum and the Pu' er tea, after fermentation, the components supplement each other and have synergistic effect, and the radix millettiae speciosae tea has good effects of reducing blood sugar, reducing blood fat and the like.
Description
Technical Field
The invention belongs to the technical field of beverages, and particularly relates to a beautiful millettia root-intelligence-improving tea beverage as well as a preparation method and application thereof.
Background
With the increasing living standard, the demand for health is more highly desired. For people with normal body weight, people who want to keep body balance are worried about obesity causing different diseases. For people with heavy weight, especially women, who love beauty, it is desirable to lose weight to gain beauty and health. For the patient population with hyperlipidemia and hyperglycemia, the daily stability of blood lipid and blood glucose is desired. At present, China faces serious public health problems, such as obesity, hyperlipidemia, diabetes and the like, and is particularly obvious for middle-aged and elderly people. Diet therapy, exercise therapy, and drug therapy are commonly used for the treatment of obesity. Dietotherapy is a method for controlling body weight by suppressing the total intake of energy, and even if weight loss is successful, it causes physical problems such as malnutrition and frequent hunger sensation, and it cannot be used for a long period of time. When exercise therapy is used, it is difficult to maintain the exercise in a state that continuous and violent exercise consuming oxygen is required. Most of the weight-reducing medicines in the pharmacotherapy have toxic and side effects with different degrees after being taken, and are not suitable for long-term taking. For the treatment of hyperlipidemia and diabetes, because the adopted chemical drugs can generate toxic and side effects with different degrees and are easy to relapse after the drug is stopped, the method for treating and conditioning hyperlipidemia and diabetes is not suitable for the method of simple chemical drugs.
Disclosure of Invention
The invention aims to overcome the defects in the prior art and provides a beautiful millettia root-intelligence-improving tea beverage as well as a preparation method and application thereof.
The invention provides a composition for preparing a tea beverage for reducing blood sugar and blood fat, which comprises the following components in parts by weight:
40-50 parts of beautiful millettia root, such as 40 parts, 41 parts, 42 parts, 43 parts, 44 parts, 45 parts, 46 parts, 47 parts, 48 parts, 49 parts and 50 parts,
20-30 parts of alpinia oxyphylla, such as 20 parts, 21 parts, 22 parts, 23 parts, 24 parts, 25 parts, 26 parts, 27 parts, 28 parts, 29 parts and 30 parts,
10-20 parts of galangal flower, such as 10 parts, 11 parts, 12 parts, 13 parts, 14 parts, 15 parts, 16 parts, 17 parts, 18 parts, 19 parts and 20 parts,
10-20 parts of chrysanthemum, such as 10 parts, 11 parts, 12 parts, 13 parts, 14 parts, 15 parts, 16 parts, 17 parts, 18 parts, 19 parts and 20 parts,
40-50 parts of Pu' er tea, such as 40 parts, 41 parts, 42 parts, 43 parts, 44 parts, 45 parts, 46 parts, 47 parts, 48 parts, 49 parts and 50 parts.
Preferably, the components of the composition comprise, in parts by weight: 45 parts of beautiful millettia root, 25 parts of alpinia oxyphylla, 15 parts of galangal flower, 15 parts of chrysanthemum and 45 parts of Pu' er tea.
Unless otherwise stated, the alpinia oxyphylla in the invention is dry alpinia oxyphylla obtained by steaming fresh alpinia oxyphylla in a water-proof manner and then drying the fresh alpinia oxyphylla in the sun until the fresh alpinia oxyphylla is completely dehydrated.
If not specifically stated, the galangal flower in the invention is dried galangal flower which is obtained by steaming fresh galangal flower in water and then drying in the sun until the galangal flower is completely dehydrated.
If not specifically stated, the chrysanthemum is dried chrysanthemum which is obtained by steaming fresh chrysanthemum in a water-proof way, and then drying the steamed chrysanthemum in the sun until the chrysanthemum is completely dehydrated.
Unless otherwise stated, the Pu' er tea is prepared from Yunnan big-leaf sunned raw tea by the traditional process (moist (the water content is less than or equal to 30%) → pile fermentation (the temperature is less than 60 ℃) → pile turning, deblocking → tedding → sieving → inspection → finished product).
Unless otherwise specified, the beautiful millettia root in the invention is the traditional Chinese medicine beautiful millettia root.
In a second aspect of the invention, a millettia speciosa champ-alpine oxyphylla tea beverage is provided, which is prepared by fermenting the composition of the first aspect of the invention.
In a third aspect of the present invention, there is provided a method for preparing a beautiful millettia root-intelligence promoting tea beverage according to the second aspect of the present invention, comprising the steps of:
(1) taking Pu' er tea and radix Millettiae Speciosae powder, adding appropriate amount of water, and decocting for 2-5 hr;
(2) adding Alpinia oxyphylla, Alpinia galanga, and flos Chrysanthemi, and decocting for 20-30 min;
(3) fermenting at 35-40 deg.C for 3-5 days;
(4) filtering, and collecting filtrate.
The beautiful millettia root-intelligence promoting tea beverage can be prepared into a finished product liquid beverage for direct drinking, and in the preparation method, the beautiful millettia root-intelligence promoting tea beverage is further prepared by the step (5) of adding water for dilution until the ratio of the final product to the composition of the first aspect of the invention is 40-50ml:1g, subpackaging and sterilizing.
Wherein, the beautiful millettia root-intelligence promoting tea drink can be prepared into solid powder, and is added with water for blending when being drunk, and the preparation method also comprises the step (5) of concentration and drying.
In a fourth aspect of the present invention, there is provided a use of the composition according to the first aspect of the present invention or the beautiful millettia root-tea beverage according to the second aspect of the present invention in the preparation of a hypoglycemic and/or hypolipidemic product.
The radix millettiae speciosae tea is prepared by combining radix millettiae speciosae, the alpinia galanga, the chrysanthemum and the Pu' er tea, after fermentation, the components supplement each other and have synergistic effect, and the radix millettiae speciosae tea has good effects of reducing blood sugar, reducing blood fat and the like.
Detailed Description
The invention will be better understood by reference to the following examples. The examples do not specify particular techniques or conditions, and are performed according to the techniques or conditions described in the literature in the art or according to the product specifications. The reagents or instruments used are not indicated by the manufacturer, and are all conventional products commercially available.
If not specifically stated, the alpinia oxyphylla flower in the invention is dry alpinia oxyphylla flower which is steamed in a water-proof way and then dried in the sun until the flower is completely dehydrated, the galangal flower in the invention is dry alpinia oxyphylla flower which is steamed in a water-proof way and then dried in the sun until the flower is completely dehydrated, the chrysanthemum in the invention is dry chrysanthemum which is steamed in a water-proof way and then dried in the sun until the flower is completely dehydrated, the puer tea in the invention is puer tea prepared by drying sun green Mao tea of Yunnan big leaves according to the traditional process (moisture (the water content is less than or equal to 30%) → pile fermentation (the temperature is less than 60 ℃) → turning over, deblocking → tedding → sifting → checking → finished product), and the Millettia speciosa in the invention is traditional Chinese medicine Millettia speciosa.
Example 1
The millettia speciosa champ-alpine oxyphylla tea beverage is prepared from a composition for preparing a tea beverage with the effects of reducing blood sugar and blood fat, wherein the composition comprises the following components in parts by weight: 45 parts of beautiful millettia root, 25 parts of alpinia oxyphylla, 15 parts of galangal flower, 15 parts of chrysanthemum and 45 parts of Pu' er tea.
The preparation method comprises the following steps:
(1) taking Pu' er tea and radix Millettiae Speciosae powder, adding appropriate amount of water, and decocting for 3 hr;
(2) adding Alpinia oxyphylla, Alpinia galanga, and flos Chrysanthemi, and decocting for 30 min;
(3) fermenting at 35-40 deg.C for 4 days;
(4) filtering to obtain filtrate;
(5) adding water to dilute the mixture until the ratio of the final product to the composition in the embodiment is 50ml to 1g, subpackaging and sterilizing to obtain the traditional Chinese medicine composition.
Example 2
The millettia speciosa champ-alpine oxyphylla tea beverage is prepared from a composition for preparing a tea beverage with the effects of reducing blood sugar and blood fat, wherein the composition comprises the following components in parts by weight: 50 parts of beautiful millettia root, 20 parts of alpinia oxyphylla flower, 20 parts of galangal flower, 10 parts of chrysanthemum and 50 parts of Pu' er tea.
The preparation method comprises the following steps:
(1) taking Pu' er tea and radix Millettiae Speciosae powder, adding appropriate amount of water, and decocting for 4 hr;
(2) adding Alpinia oxyphylla, Alpinia galanga, and flos Chrysanthemi, and decocting for 20 min;
(3) fermenting at 35-40 deg.C for 3 days;
(4) filtering to obtain filtrate;
(5) adding water to dilute the mixture until the ratio of the final product to the composition in the embodiment is 50ml to 1g, subpackaging and sterilizing to obtain the traditional Chinese medicine composition.
Example 3
The millettia speciosa champ-alpine oxyphylla tea beverage is prepared from a composition for preparing a tea beverage with the effects of reducing blood sugar and blood fat, wherein the composition comprises the following components in parts by weight: 40 parts of beautiful millettia root, 30 parts of alpinia oxyphylla flower, 10 parts of galangal flower, 20 parts of chrysanthemum and 40 parts of Pu' er tea.
The preparation method comprises the following steps:
(1) taking Pu' er tea and radix Millettiae Speciosae powder, adding appropriate amount of water, and decocting for 2 hr;
(2) adding Alpinia oxyphylla, Alpinia galanga, and flos Chrysanthemi, and decocting for 30 min;
(3) fermenting at 35-40 deg.C for 5 days;
(4) filtering to obtain filtrate;
(5) adding water to dilute the mixture until the ratio of the final product to the composition in the embodiment is 40ml to 1g, subpackaging and sterilizing to obtain the traditional Chinese medicine composition.
Comparative example 1
This comparative example differs from example 1 in that the components of the composition do not contain beautiful millettia root and are prepared by the following steps:
(1) adding appropriate amount of water into Pu her tea, and decocting for 3 hr;
(2) adding Alpinia oxyphylla, Alpinia galanga, and flos Chrysanthemi, and decocting for 30 min;
(3) fermenting at 35-40 deg.C for 4 days;
(4) filtering to obtain filtrate;
(5) adding water to dilute the mixture until the ratio of the final product to the composition of the comparative example is 50ml:1g, subpackaging and sterilizing to obtain the traditional Chinese medicine composition.
Comparative example 2
The comparative example differs from example 1 in that the composition does not contain alpinia oxyphylla in its components and is prepared by the following steps:
(1) taking Pu' er tea and radix Millettiae Speciosae powder, adding appropriate amount of water, and decocting for 3 hr;
(2) adding flos Alpiniae Officinarum and flos Chrysanthemi, and decocting for 30 min;
(3) fermenting at 35-40 deg.C for 4 days;
(4) filtering to obtain filtrate;
(5) adding water to dilute the mixture until the ratio of the final product to the composition of the comparative example is 50ml:1g, subpackaging and sterilizing to obtain the traditional Chinese medicine composition.
Comparative example 3
The comparative example differs from example 1 in that the composition does not contain galangal flowers and chrysanthemum in its components and is prepared by the following steps:
(1) taking Pu' er tea and radix Millettiae Speciosae powder, adding appropriate amount of water, and decocting for 3 hr;
(2) adding flos Alpinae Oxyphyllae, and decocting for 30 min;
(3) fermenting at 35-40 deg.C for 4 days;
(4) filtering to obtain filtrate;
(5) adding water to dilute the mixture until the ratio of the final product to the composition of the comparative example is 50ml:1g, subpackaging and sterilizing to obtain the traditional Chinese medicine composition.
Comparative example 4
Compared with the embodiment 1, the difference of the comparative example is that the components of the composition do not contain Pu' er tea, and the preparation method comprises the following steps:
(1) taking radix Millettiae Speciosae powder, adding appropriate amount of water, and decocting for 3 hr;
(2) adding Alpinia oxyphylla, Alpinia galanga, and flos Chrysanthemi, and decocting for 30 min;
(3) fermenting at 35-40 deg.C for 4 days;
(4) filtering to obtain filtrate;
(5) adding water to dilute the mixture until the ratio of the final product to the composition of the comparative example is 50ml:1g, subpackaging and sterilizing to obtain the traditional Chinese medicine composition.
Animal experiment for reducing blood fat
1) The beautiful millettia root-intellectual development tea beverage of example 1 of the present invention was used as a sample, and the tea beverages of comparative examples 1 to 4 were used as controls.
2) Experimental animals: SD healthy SPF male rats were selected.
3) Dosage: the experimental group (inventive example 1) and the control groups 1 to 4 (inventive comparative examples 1 to 4) were orally administered to rats three times a day in an intragastric administration volume of 0.5mL/100g mouse weight, and various indexes were measured after continuous intragastric administration for 30 days. Meanwhile, a blank group is arranged, and water is used for replacing the tea beverage.
4) And (3) high-fat feed formula: 78.8% of basal feed, 1% of cholesterol, 10% of egg yolk powder, 10% of lard oil and 0.2% of bile salt. The basic feed is produced by a Qinglongshan animal breeding farm in Jiangning district of Nanjing City.
5) The experimental method comprises the following steps: after feeding the rats with the high-fat feed for 7-10 days, detecting serum Total Cholesterol (TC) values and serum Triglyceride (TG) values of the fasting rats, selecting 60 rats with the serum total cholesterol value of more than 7.0mmol/L and the serum triglyceride of more than 2.0mmol/L, randomly dividing the rats into 6 groups, and feeding the rats with the basic feed:
experimental groups: gavage the tea beverage of example 1 of the present invention,
control group 1: gavage the tea beverage of comparative example 1 of the present invention,
control group 2: gavage the tea beverage of comparative example 2 of the present invention,
control group 3: gavage the tea beverage of comparative example 3 of the present invention,
control group 4: gavage the tea beverage of comparative example 4 of the present invention,
blank group: and (5) irrigating stomach water.
After 30 days of administration of the tea beverage of the present invention, fasting was performed for 16 hours, and serum total cholesterol and triglyceride were measured in each group of rats.
6) Determination of serum total cholesterol and triglyceride
Blood is taken, centrifuged at 3000r/min for 10 minutes to separate serum, the serum is taken and measured by a SELECTRA-E full-automatic biochemical analyzer, the content of total cholesterol and triglyceride in the serum can be measured, and the result is shown in Table 1.
TABLE 1 (average)
As can be seen from Table 1, the difference between the experimental group and the control group 1-4 of serum total cholesterol and triglyceride was not significant when compared with the blank group before the tea beverage of the present invention was administered, whereas the experimental group was significantly reduced in serum total cholesterol and triglyceride when compared with the control group 1-4 and blank group 30 days after the tea beverage of the present invention was administered. The experimental results show that the tea beverage has good function of reducing blood fat.
Animal experiment for reducing blood sugar
1) The beautiful millettia root-intellectual development tea beverage of example 1 of the present invention was used as a sample, and the tea beverages of comparative examples 1 to 4 were used as controls.
2) Experimental animals: healthy C57BL male mice weighing (22 days 2) g were selected.
3) Dosage: the experimental group (inventive example 1) and the control groups 1 to 4 (inventive comparative examples 1 to 4) were orally administered to rats three times a day in an intragastric administration volume of 0.5mL/100g mouse weight, and various indexes were measured after continuous intragastric administration for 30 days. Meanwhile, a blank group is arranged, and water is used for replacing the tea beverage.
4) The formula of the high-sugar and high-fat feed comprises the following components: 66.5 percent of basic feed, 2.5 percent of cholesterol, 20 percent of white granulated sugar, 10 percent of lard and 1 percent of bile salt by weight. The basic feed is produced by a Qinglongshan animal breeding farm in Jiangning district of Nanjing City.
5) The experimental method comprises the following steps: after the mice are fed with the high-sugar high-fat feed for 20-30 days, detecting the change of fasting blood sugar, selecting 60 mice with the blood sugar value being more than or equal to 14.9mmol/L, randomly dividing the mice into 6 groups, and changing the feeding into the basic feed:
experimental groups: gavage the tea beverage of example 1 of the present invention,
control group 1: gavage the tea beverage of comparative example 1 of the present invention,
control group 2: gavage the tea beverage of comparative example 2 of the present invention,
control group 3: gavage the tea beverage of comparative example 3 of the present invention,
control group 4: gavage the tea beverage of comparative example 4 of the present invention,
blank group: and (5) irrigating stomach water.
After 30 days of administration of the tea beverage of the present invention, fasting was performed for 16 hours, and fasting blood glucose changes were measured.
6) Serum blood glucose determination
Blood was collected, centrifuged at 3000r/min for 10 minutes to separate serum, and the blood glucose content was measured by a GT-1810 blood glucose meter, the results of which are shown in Table 2.
TABLE 2 (mean, unit:)
As can be seen from Table 2, the difference between serum Total Cholesterol (TC) and Triglyceride (TG) in the experimental group and the control group 1 to 4 before administration of the tea beverage of the present invention was not significant, whereas the blood glucose level in the sample group was significantly reduced in comparison with the control group 1 to 4 and the blank group 30 days after administration of the tea beverage of the present invention. The above experimental results show that the tea beverage of the present invention has a good blood sugar lowering effect.
The embodiments of the present invention have been described in detail, but the embodiments are merely examples, and the present invention is not limited to the embodiments described above. Any equivalent modifications and substitutions to those skilled in the art are also within the scope of the present invention. Accordingly, equivalent changes and modifications made without departing from the spirit and scope of the present invention should be covered by the present invention.
Claims (7)
1. The composition for preparing the tea beverage for reducing blood sugar and blood fat is characterized by comprising the following components in parts by weight: 40-50 parts of beautiful millettia root, 20-30 parts of alpinia oxyphylla flower, 10-20 parts of galangal flower, 10-20 parts of chrysanthemum and 40-50 parts of Pu' er tea.
2. The composition according to claim 1, which comprises the following components in parts by weight: 45 parts of beautiful millettia root, 25 parts of alpinia oxyphylla, 15 parts of galangal flower, 15 parts of chrysanthemum and 45 parts of Pu' er tea.
3. An millettia speciosa-alpinia oxyphylla tea beverage characterized by being prepared by fermenting the composition of claim 1 or 2.
4. A method for preparing the beautiful millettia root-intelligence-improving tea beverage as claimed in claim 3, comprising the steps of:
(1) taking Pu' er tea and radix Millettiae Speciosae powder, adding appropriate amount of water, and decocting for 2-5 hr;
(2) adding Alpinia oxyphylla, Alpinia galanga, and flos Chrysanthemi, and decocting for 20-30 min;
(3) fermenting at 35-40 deg.C for 3-5 days;
(4) filtering, and collecting filtrate.
5. The preparation method according to claim 4, further comprising the step (5) of adding water to dilute the mixture until the ratio of the final product to the composition is 40-50ml:1g, subpackaging and sterilizing.
6. The method according to claim 4, further comprising the step of (5) concentrating and drying.
7. Use of the composition of claim 1 or 2, or the millettia speciosa champ-alpine tea beverage of claim 3, for the preparation of a product for lowering blood sugar and/or blood fat.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011570031.2A CN112690351B (en) | 2020-12-26 | 2020-12-26 | Millettia speciosa-intelligence-improving tea beverage and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011570031.2A CN112690351B (en) | 2020-12-26 | 2020-12-26 | Millettia speciosa-intelligence-improving tea beverage and preparation method and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN112690351A true CN112690351A (en) | 2021-04-23 |
| CN112690351B CN112690351B (en) | 2023-10-27 |
Family
ID=75511096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011570031.2A Active CN112690351B (en) | 2020-12-26 | 2020-12-26 | Millettia speciosa-intelligence-improving tea beverage and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112690351B (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011148837A (en) * | 2003-12-26 | 2011-08-04 | Taisho Pharmaceutical Co Ltd | Lipase inhibitor |
| CN104172312A (en) * | 2014-08-21 | 2014-12-03 | 武汉旭东食品有限公司 | Iced tea melon seeds and production method thereof |
| CN104621296A (en) * | 2013-11-11 | 2015-05-20 | 南京拓鉒医药科技有限公司 | Blood lipid, glucose and pressure regulating traditional Chinese medicine combined tea drink |
| CN106173125A (en) * | 2016-07-06 | 2016-12-07 | 安徽米乐食品有限公司 | A kind of looks improving and the skin nourishing nutrition chocolate and preparation method thereof |
| CN107439751A (en) * | 2017-10-14 | 2017-12-08 | 蓝本祥 | A kind of preparation method of beautiful millettia root tea beverage |
| CN109652202A (en) * | 2019-01-22 | 2019-04-19 | 陈子久 | A kind of intelligence development safflower tea oil and preparation method thereof |
| CN110477159A (en) * | 2019-09-12 | 2019-11-22 | 三亚市林业科学研究院 | A kind of preparation method of intelligence development jasmine tea and its intelligence development jasmine tea of preparation |
-
2020
- 2020-12-26 CN CN202011570031.2A patent/CN112690351B/en active Active
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011148837A (en) * | 2003-12-26 | 2011-08-04 | Taisho Pharmaceutical Co Ltd | Lipase inhibitor |
| CN104621296A (en) * | 2013-11-11 | 2015-05-20 | 南京拓鉒医药科技有限公司 | Blood lipid, glucose and pressure regulating traditional Chinese medicine combined tea drink |
| CN104172312A (en) * | 2014-08-21 | 2014-12-03 | 武汉旭东食品有限公司 | Iced tea melon seeds and production method thereof |
| CN106173125A (en) * | 2016-07-06 | 2016-12-07 | 安徽米乐食品有限公司 | A kind of looks improving and the skin nourishing nutrition chocolate and preparation method thereof |
| CN107439751A (en) * | 2017-10-14 | 2017-12-08 | 蓝本祥 | A kind of preparation method of beautiful millettia root tea beverage |
| CN109652202A (en) * | 2019-01-22 | 2019-04-19 | 陈子久 | A kind of intelligence development safflower tea oil and preparation method thereof |
| CN110477159A (en) * | 2019-09-12 | 2019-11-22 | 三亚市林业科学研究院 | A kind of preparation method of intelligence development jasmine tea and its intelligence development jasmine tea of preparation |
Non-Patent Citations (2)
| Title |
|---|
| 王辉等: "高良姜提取物的降血糖活性", 《热带生物学报》 * |
| 王辉等: "高良姜提取物的降血糖活性", 《热带生物学报》, vol. 5, no. 2, 25 June 2014 (2014-06-25), pages 179 - 181 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN112690351B (en) | 2023-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104982928B (en) | A kind of japanese yew fruit health care ferment and preparation method thereof | |
| CN102965237B (en) | Mulberry-ganoderma fruit wine and production method thereof | |
| KR101332321B1 (en) | Health food fermented using effective micro-organisms with herbal medicine and manufacturing method thereof | |
| JP2023538664A (en) | Compositions of ginsenoside Rg3 and ginsenoside Rg5 and their pharmaceutical uses, including antitumor effects | |
| KR20110033644A (en) | Composition for curing hangover and method manufacturing thereof | |
| CN108392519A (en) | A kind of hypoglycemic composition and its preparation and application | |
| CN111528470A (en) | Preparation method of calcium roxburgh rose complex, product and application thereof | |
| CN104906361A (en) | Hypolipidemic yellow rice wine and making method thereof | |
| CN105983016B (en) | A pharmaceutical composition containing silybin | |
| CN108034547A (en) | A kind of bitter buckwheat paste flavor wine and preparation method thereof | |
| CN103497867B (en) | Mango banana fruit wine and production method thereof | |
| US20030232099A1 (en) | Health-care products and methods for preparing and using the same | |
| CN112690351A (en) | Millettia speciosa-intelligence-benefiting tea beverage as well as preparation method and application thereof | |
| CN111165709A (en) | Solid beverage with blood sugar control function and preparation method thereof | |
| JP2010100530A (en) | Anti-obestic agent | |
| KR101467407B1 (en) | Antidiabetic food composition with the extract of Dendropanax morbifera | |
| CN116058496B (en) | Composite tartary buckwheat instant tablet and production method thereof | |
| CN111543638A (en) | Sea cucumber polysaccharide product with auxiliary blood sugar reducing effect and preparation method thereof | |
| CN110623266A (en) | Health food for assisting in reducing blood sugar and preparation method thereof | |
| CN108936577A (en) | A kind of compound group preparation method of the edible natural with cardiovascular protective effect | |
| CN1160095C (en) | Antisanility health-care cream and its preparing process | |
| CN104304379A (en) | Health-care fresh-keeping biscuits capable of assisting in lowering blood glucose and production method thereof | |
| CN110240995A (en) | A kind of bitter buckwheat red yeast rice medlar health preserving vinegar and its production technology | |
| CN109567194A (en) | A kind of selenium-rich highland barley clyster powder, processing method and its application | |
| CN114304609B (en) | Rose ferment with lipid-lowering effect and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |